Compare Lam Research Corporation (LRCX) vs Health Care Select Sector SPDR Fund (XLV) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Lam Research Corporation vs Health Care Select Sector SPDR Fund — how do they compare? Lam Research Corporation trades at $323 (market cap $383.63B), while Health Care Select Sector SPDR Fund trades at $160.2. The key difference: Lam Research Corporation pays a 0.34% dividend while Health Care Select Sector SPDR Fund pays none, and Health Care Select Sector SPDR Fund is trading nearer its 52-week high, Lam Research Corporation nearer its low. Which is the better fit depends on your goals.
| LRCX | XLV | |
|---|---|---|
Market Cap | $383.63B | — |
Sector | Technology | — |
52-Week High | $433.33 | $164.48 |
52-Week Low | $94.84 | $129.01 |
Enterprise Value | $382.61B | — |
Dividend Yield | 0.34% | — |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Lam Research Corporation
Lam Research manufactures equipment used to fabricate semiconductors. The firm is focused on the etching, deposition, and clean markets, which are key steps in the semiconductor manufacturing process, especially for 3D NAND flash storage, advanced DRAM, and leading-edge logic/foundry chipmakers. Lam's flagship Kiyo, Vector, and Sabre products are sold in all major geographies to key customers such as Samsung Electronics, Micron, Intel, and Taiwan Semiconductor Manufacturing.
Read more on LRCX →About Health Care Select Sector SPDR Fund
In seeking to track the performance of the index, the fund employs a replication strategy. It generally invests substantially all, but at least 95%, of its total assets in the securities comprising the index. The index includes companies from the following industries: pharmaceuticals; health care equipment & supplies; health care providers & services; biotechnology; life sciences tools & services; and health care technology. The fund is non-diversified.
Read more on XLV →
